Press Releases and Media

Seer Images


News
Unbiased Proteomics Can Open New Doors in Cancer Research

Mar
2022

Untargeted proteomics technology at scale to identify lung cancer-associated variants

Read more in Clinical Lab Manager on how a plasma-based biomarker discovery platform for non-small cell lung cancer was developed using Seer’s unbiased proteogenomic approach to map protein variants arising from a single gene.

             DOWNLOAD
News
simultaneous superior performance

Mar
2022

Study demonstrating superior performance across depth, precision, and throughput

Published results highlight simultaneous superior performance across depth, precision, and throughput versus conventional plasma proteomics workflows.

VIEW ARTICLE
News
omid farokhzad

Mar
2022

Seer CEO profiled in the San Francisco Business Times

Seer CEO Omid Farohkzad was profiled in the San Francisco Business Times. Read more on his unique career path, what inspires him to continue making an impact in life sciences, and his vision of proteomics for the future of healthcare.

VIEW ARTICLE
Press Releases
seer_sciex_disc_logos

Jan
2022

Seer, Discovery Life Sciences and SCIEX Sign Consortium Agreement

Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies.

VIEW ARTICLE
Press Releases
seer_white_logo

Jan
2022

Seer Announces Broad Commercial Release and Centers of Excellence

Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program.

VIEW ARTICLE
News
Seer product family v2

Nov
2021

This article in GenomeWeb shines a spotlight on customers using the Proteograph Product Suite.

Researchers from the Oregon Health & Science University, the Broad Institute, Sanford Burnham Prebys Medical Discovery Institute, and proteomics software company Protein Metrics presented data and their experience using Seer’s Proteograph technology. (Premium content, sign in may be required.)

VIEW ARTICLE
News
Seer Welcomes Rachel Haurwitz

Nov
2021

Seer Expands Board Of Directors

Seer Welcomes Rachel Haurwitz, Ph.D. to Board of Directors

VIEW ARTICLE
News
GEN_40th_web

Oct
2021

Multidisciplinary approaches will greatly expand our knowledge of biology and human health

Seer CEO Omid Farokhzad shares his perspective on how multidisciplinary approaches, including proteomics and genomics, will greatly expand our knowledge of biology and human health as part of Genetic Engineering & Biotechnology News’ 40th anniversary issue.

VIEW ARTICLE
News
Omics news header

Oct
2021

How omics will drive the next generation of surrogate endpoints

This article in BioCentury explains how ‘omics technologies can improve the runway to drug approvals across diverse disease areas. For mass-spectrometry-based proteomic and metabolomic measurements the ability to capture a wider range of biological complexity is a more direct reflection of a patient’s state of health. (Subscription required)

VIEW ARTICLE
Podcasts
The Interference Between You and Your Health

Jul
2021

The Playbook Podcast Interview: The Interference Between You and Your Health

Dr. Omid Farokhzad, Chair, CEO and Founder of Seer, discusses how Seer’s cutting edge work with protein and proteomics is removing technological barriers and providing scientists with better tools to make breakthroughs than ever before. Watch the video here

Listen to Interview
Podcasts
Mapping the Universe of Human Proteins

Jul
2021

BioReport Podcast Interview: Mapping the Universe of Human Proteins

BioReport Podcast: CEO Omid Farokhzad explains why, although great progress has been made in understanding the human genome, the human proteome remains relatively unexplored.

Listen to Interview
News
Motley Fool Interview: The future of proteomics

Jun
2021

Motley Fool Interview: The future of proteomics

Motley Fool: interview with CEO Omid Farokhzad on the future of proteomics.

VIEW VIDEO
News
Benzinga Interview: The Importance of Proteomics

May
2021

Benzinga Interview: The Importance of Proteomics

Benzinga: interview with CEO Omid Farokhzad on the importance of proteomics

VIEW VIDEO
Press Releases
Seer signs agreement with Sciex

Mar
2021

Seer signs agreement with Sciex

Seer signs agreement with Sciex: Seer and SCIEX have signed a commercial agreement to provide end to end unbiased proteomics solutions.

VIEW ARTICLE
Press Releases
Deep and Mostafa

Feb
2021

Seer adds board members

Seer adds board members: Seer appoints Deep Nishar and Mostafa Ronaghi, Ph.D. to its Board of Directors

VIEW ARTICLE
Press Releases
Bruker Agreement with Seer

Jan
2021

Bruker Agreement with Seer

Seer and Bruker Sign Commercial Agreement to Expand Market for Unbiased, Deep Proteomics

VIEW ARTICLE
Press Releases
Thermo Fisher Scientific Logo

Jan
2021

Seer Signs Commercial Agreement

Seer Signs Commercial Agreement to Provide Complete End-to-End Solution for Unbiased, Deep, Rapid and Large-Scale Proteomics

VIEW ARTICLE
Press Releases
seer_white_logo

Dec
2020

Seer Announces Pricing of Initial Public Offering

Seer announced the pricing of its initial public offering of 9,210,527 shares of Class A common stock.

VIEW ARTICLE
Press Releases
Friedman - Seer Expands Board of Directors

Sep
2020

Seer Expands Board of Directors

Seer Appoints Catherine Friedman to its Board of Directors

VIEW ARTICLE
Press Releases
PrognomIQ Spin Out Financing

Sep
2020

PrognomIQ Spin Out Financing

Seer Announces Spin Out of PrognomIQ with $55 Million Initial Financing

VIEW ARTICLE
Press Releases
Nature Communications Publication

Jul
2020

Nature Communications Publication Demonstrating Performance

Seers Announces Publication in Nature Communications Demonstrating Performance, Scalability and Utility of its Platform Technology for Deep, Unbiased Proteomics.

VIEW ARTICLE

Seer Images

Seer Images
Omid Cameron Farokhzad

Jul
2021

Omid Farokhzad

Omid Farokhzad is the Chair and Chief Executive Officer for Seer.

             DOWNLOAD
Seer Images
Seer Nanoparticles

Jun
2021

Seer Nanoparticles

Seer’s proprietary engineered nanoparticles. Each nanoparticle consists of a magnetic core and a surface with unique physicochemical properties.

             DOWNLOAD
Seer Images
Protein-Covered Nanoparticle

Jun
2021

Protein-Covered Nanoparticle

Proteins bind to Seer’s proprietary engineered nanoparticles first by concentration, and then by affinity displacement to form a protein corona.

             DOWNLOAD
Seer Images
Proteograph-Product-Suite_thumb

Jun
2021

Proteograph Product Suite

Seer’s Proteograph Product Suite is designed to enable unbiased, deep and rapid proteomics at scale.

             DOWNLOAD
Seer Images
seer brandmark rgb full

May
2021

Seer Brandmark RGB

Hi resolution Seer logo in RGB for digital use.

             DOWNLOAD
Seer Images
seer brandmark rgb black

May
2021

Seer Brandmark – Black

High resolution Seer logo in black for digital use.

             DOWNLOAD
Seer Images
seer_logo_rev

May
2021

Seer Brandmark – White

Reverse high resolution Seer logo in white for digital use.

             DOWNLOAD